Hillary Wright Joins Theralogix’s Medical Advisory Board

ROCKVILLE, MD, October 1, 2026 /CourierPR/ -- Theralogix, a national leader in the supplement industry, has announced the addition of Hillary M. Wright, MEd, RDN, LDN, to its Medical Advisory Board. Wright’s extensive expertise in nutrition and women’s health further strengthens the company’s commitment to science and evidence-based supplements.

Wright brings more than three decades of experience as a registered dietitian, educator, and author, with expertise in women’s health, fertility, and metabolic health. She currently serves as Director of Nutrition at The Wellness Center at Boston IVF, where she specializes in nutrition and women’s health, and as a Senior Nutritionist at Dana-Farber Cancer Institute in Boston, Massachusetts. Previously, she spent more than a decade as a nutrition educator with Harvard Vanguard Medical Associates, counseling patients of all ages on weight management, diabetes, cardiovascular health, and other chronic health concerns.

A respected author, speaker, and educator, Wright has written extensively on the role of nutrition and lifestyle in supporting women’s and metabolic health. She has also presented at professional conferences and national meetings on topics including PCOS/PMOS, fertility, women’s health, diabetes prevention, and nutrition during and after cancer treatment. Her extensive clinical experience and commitment to evidence-based nutrition bring a valuable perspective to the Theralogix Medical Advisory Board.

Theralogix sets the standard for premium, research-backed nutritional supplements. Each product in its full line of supplements is independently certified by NSF for content accuracy and freedom from contaminants. The company has been a top physician-recommended brand for over two decades.

Theralogix’s Medical Advisory Board (MAB) plays a vital role in solidifying this dedication to science-backed products. Made up of a carefully selected group of physician faculty from leading U.S. medical schools, clinical specialists, and research scientists, the MAB evaluates and approves new product formulations, while offering guidance to improve existing ones.

Theralogix’s addition of Wright to its Medical Advisory Board underscores the company’s commitment to science and evidence-based supplements. With her extensive experience and expertise, Wright brings a unique perspective to the board, further strengthening Theralogix’s commitment to providing high-quality, research-backed products to its customers.